| 经导管栓塞化疗中晚期肝癌 |
| |
| 引用本文： | 黄永火,冯新民,欧阳羽. 经导管栓塞化疗中晚期肝癌[J]. 中华肝脏病杂志, 1998, 6(4): 221-223 |
| |
| 作者姓名： | 黄永火 冯新民 欧阳羽 |
| |
| 作者单位： | 重庆医科大学附属第一医院 |
| |
| 摘 要： | 目的研究中晚期肝癌非手术治疗的最佳方案。方法135例随机分成Ａ、Ｂ、Ｃ３组。Ａ组肝动脉内灌注化疗药物，Ｂ组药物灌注加碘油乳剂及明胶海绵栓塞，Ｃ组碘油乳剂及明胶海绵栓塞。结果３组平均生存期为5.7月，10.6月和8.7月；0.5、１、２、３年生存率Ａ组51.6％、12.9％，无
|
| 关 键 词： | 肝癌 化疗 栓塞 药物 |
TRANSCATHETER CHEMO-EMBOLIZATION OF HEPATIC MIDDLE-LATE CANCER |
| |
| Huang Yonghuo,Feng Xinmin,Ou Yangyu,et al.. TRANSCATHETER CHEMO-EMBOLIZATION OF HEPATIC MIDDLE-LATE CANCER[J]. Chinese journal of hepatology, 1998, 6(4): 221-223 |
| |
| Authors: | Huang Yonghuo Feng Xinmin Ou Yangyu et al. |
| |
| Affiliation: | Huang Yonghuo,Feng Xinmin,Ou Yangyu,et al. Department of Radiology,First Affiliated Hospital of Chongqing Medical University,Chongqing 400016 |
| |
| Abstract: | Objective The best nonsurgical therapeutic scheme of hepatic middle-late cancer was studied. Methods 135 cases were divided randomly into 3 groups according to the method of therapy, group A hepatic transarterial chemotherapy alone; group B, chemotherapy, lipiodol and gelfoam embolization; group C, lipiodol and gelfoam embolization. Results The median durations of the three gropus survival were 5 7, 10 6 and 8 7 months respectively. The survival rates at 1/2, 1, 2, 3 years; group A were 51 6% and 12 9%, group B were 89 6%, 43 8%, 22 9% and 14 6%, group C were 87 5%, 42 9%, 21 4% and 14 4% respectively. The serum AFP value was reduced to 45 2% in group A, in 79 2% to group B and to 69 6% in group C. Conclusion These results suggest that chemoembolization is the best nonsurgical treatment for hepatic middle-late cancer. |
| |
| Keywords: | Hepatic cancer Chemotherapy Embolization Medicine |
| 本文献已被 CNKI 维普 万方数据 等数据库收录！ |
|
